Eva Larocque, MD
Psychiatry · Great Falls, MTNPI 1346271061
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,327 of the $1,746 with a category attached, or 76.0%. 9 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 29.9% of the total. Reporting peaked in 2019 at $497 and has fallen 65.1% since, to $174 in 2025.
Across 85 payments — averaging $20.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$521
- Johnson & Johnson$306
- AbbVie$281
- Otsuka America Pharmaceutical, Inc.$199
- Neurocrine Biosciences, Inc.$177
- Alkermes, Inc.$134
- plus $128 from 3 others
What the payments were for
- Food & beverage$1,32776%
- Education$41924%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $521 |
| Johnson & Johnson | 21 | $306 |
| AbbVie(2 entities) | 20 | $281 |
| Otsuka America Pharmaceutical, Inc. | 9 | $199 |
| Neurocrine Biosciences, Inc. | 10 | $177 |
| Alkermes, Inc. | 7 | $134 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $52 |
| Sunovion Pharmaceuticals Inc. | 3 | $52 |
| Lundbeck LLC | 2 | $24 |
How this compares
$1,746 in reported general payments places this provider in the 85th percentile of 82 psychiatry providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 141 | $452,857 |
| AustedoDeutetrabenazine | 39 | $174,906 |
| VraylarCariprazine Hcl | 265 | $120,119 |
| Invega TrinzaPaliperidone Palmitate | 11 | $120,087 |
| Abilify AsimtufiiAripiprazole | 14 | $84,671 |
| CaplytaLumateperone Tosylate | 82 | $54,121 |
| AristadaAripiprazole Lauroxil | 15 | $52,062 |
| Abilify MaintenaAripiprazole | 19 | $51,933 |
| Paliperidone ErPaliperidone | 343 | $36,282 |
| BelsomraSuvorexant | 58 | $16,624 |
| Aripiprazole | 490 | $15,141 |
| Lurasidone Hcl | 105 | $14,651 |
| Clomipramine Hcl | 53 | $11,076 |
| Clozapine | 97 | $10,853 |
| Olanzapine | 700 | $8,696 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza, Invega | $306 | $575,628168 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $521 | $174,90639 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Asimtufii, Abilify Maintena | $199 | $136,60433 claims |
| AbbVieVraylar | $281 | $120,119265 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $52 | $54,12182 claims |
| Alkermes, Inc.Aristada | $134 | $52,06215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 82 psychiatry providers in Montana.
Other psychiatry in Great Falls
- Angela CasmierGreat Falls$2K
- Kristopher PoliakiwskiGreat Falls$553
- Graig AdersGreat Falls$192
- Patricia CalkinGreat Falls$122
- Troy StilesBillings$221K
- Erin AmatoBillings$88K
- Reza Hosseini GhomiBillings$6K
- Michael NewmanWhitefish$5K
- Justin KunzBillings$4K
- Andrew ParsonsKalispell$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.